Skip to main content
An official website of the United States government

Principal Investigators

Infections and Immunoepidemiology Branch (IIB)

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


  • Engels, Eric A., M.D., M.P.H
    HIV- and AIDS-associated cancers. Solid organ transplant-related cancers. Cancers associated with other immune-related conditions.


  • Jackson, Sarah S., Ph.D.
    Dr. Jackson's research questions ask: 1) How do cancer risk factors, incidence, and outcomes among transgender and gender diverse adults differ from cisgender adults, and 2) How do sex differences (hormones, chromosomes, etc.) influence cancer risk and survival?


  • Koshiol, Jill, Ph.D
    Infections and inflammation in association with hepatobiliary cancers
  • Kreimer, Aimee R., Ph.D
    Epidemiology of human papillomaviruses (HPV) infection and resultant cancers at multiple anatomic sites, including the oropharynx, cervix, and anus.


  • Mbulaiteye, Sam M., MBChB, M.Phil., M.Med.
    Unraveling the role of infections, immunity, and genetic factors in the etiology of Burkitt lymphoma, a malignancy that is endemic in Africa and whose risk is substantially increased in the setting of HIV/AIDS.



  • Rabkin, Charles S., M.D.
    Molecular mechanisms of infection- and inflammation-related cancers, particularly for gastric cancer and non-Hodgkin lymphoma. Epstein-Barr virus (EBV) as a co-factor with Helicobacter pylori (H. pylori), the established cause of most cancers of the noncardia stomach.


  • Shiels, Meredith S., Ph.D.
    Research includes: Quantifying cancer risk and burden in people living with HIV; estimating the impact of risk factors on changing cancer rates over time; and understanding rising rates of premature mortality in the United States.